NASDAQ:NAMS | Balance Sheet | NewAmsterdam Pharma Co N.V.

Complete source-backed balance-sheet history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$424.15M$209.7M$659.21M$411,000.00$704.45M$5.42M$72.97M$73.03M$631.42M
2026-03-31$457.61M$178.5M$658.04M$379,000.00$732.64M$8.09M$67.42M$67.42M$665.22M
2025-12-31$490M$146.24M$675.7M$383,000.00$769.28M$8.97M$85.79M$85.85M$683.43M
2025-09-30$538.41M$164.54M$732.33M$323,000.00$786.43M$3.63M$58.27M$58.36M$728.07M
2025-06-30$563.86M$175.3M$769.85M$312,000.00$815.11M$5.9M$36.51M$36.62M$778.5M
2025-03-31$748.42M$60.06M$817.3M$238,000.00$818.41M$6.09M$40.91M$41.05M$777.36M
2024-12-31$771.74M$62.45M$863.41M$242,000.00$864.62M$4.74M$106.92M$107.12M$757.5M
2024-09-30$422.73M$437.87M$231,000.00$439.19M$7.04M$41.26M$60.33M$378.86M
2024-06-30$445.35M$234,000.00$446.69M$5.28M$45.31M$59.25M$387.44M
2024-03-31$487.82M$101,000.00$488.46M$8.54M$59.73M$76.66M$411.8M
2023-12-31$340.45M$346.79M$46,000.00$347.1M$16.92M$49.9M$58.7M$288.39M
2023-09-30$331.84M
2023-06-30$373.34M
2023-03-31$398.41M
2022-12-31$477.98M$34,000.00$478.5M$11.85M$36.06M$48.43M$430.07M
2021-12-31-$113.82M
2020-12-31-$73.04M